Why Intersect ENT is an Example of Hope for the Medtech Industry

vor 13 Jahren

38 Minuten

Podcast

Podcaster

Medsider: Learn from MedTech and HealthTech Experts

Learn from proven medtech and healthtech experts. That's our primary goal with Medsider. Through uncut interviews with the world's brightest thought leaders, you'll pick up on helpful insights, lessons learned, best practices, and much more.

Wissenschaft , Heilkunde , Interviews , Wirtschaft , Gesundheit & Fitness

Beschreibung

vor 13 Jahren

The 2.3% medical device tax is burdensome. Regulatory timelines
are long (and expensive). Reimbursement is not only decreasing,
but also incredibly hard to obtain. Venture capitalists are
losing interest in early stage medical device deals. Is it all
downhill for medtech? There is no doubt the current healthcare
environment is challenging. But certainly not impossible...[read
more]

Related Articles

Are Medical Device Models the Key to Building a Lean Medtech
Startup?

Why Early Stage Medical Device Deals Aren’t as Bad as You May
Think

Substantial and Sustainable – 2 Words That Medtech Companies
Should Get Used To